
[Federal Register: September 19, 2008 (Volume 73, Number 183)]
[Rules and Regulations]               
[Page 54314]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr19se08-6]                         


[[Page 54314]]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Parts 16, 610, 640, 812, 814, 822, and 860

[Docket No. FDA-2008-N-0423]

 
FDA Regulations; Technical Amendment; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a final 
rule that appeared in the Federal Register of Monday, August 25, 2008 
(73 FR 49941). The final rule made technical amendments to several FDA 
regulations. The document was published with two inaccurate citations 
in the first paragraph of the Background Section under Supplementary 
Information. This document corrects that error.

DATES:  September 19, 2008.

FOR FURTHER INFORMATION CONTACT: Denise S[aacute]nchez, Center for 
Biologics Evaluation and Research (HFM-17), Food and Drug 
Administration, 1401 Rockville Pike, suite 200N, Rockville, MD 20852-
1448, 301-827-6210.

SUPPLEMENTARY INFORMATION: In FR Doc. E8-19654, appearing on page 49941 
in the Federal Register of Monday, August 25, 2008 (73 FR 49941), the 
following correction is made:
    On page 49941, in the first paragraph of the Background section 
under Supplementary Information, ``21 CFR 610.51'' is corrected to read 
as ``21 CFR 610.53'' and ``21 CFR 640.53'' is corrected to read as ``21 
CFR 640.51''.

    Dated: September 15, 2008.
Jeffrey Shuren,
Associate Commissioner for Policy and Planning.
[FR Doc. E8-21966 Filed 9-18-08; 8:45 am]

BILLING CODE 4160-01-S
